637
Participants
Start Date
March 14, 2017
Primary Completion Date
November 9, 2017
Study Completion Date
November 28, 2017
Co-crystal E-58425 (Tramadol/Celecoxib)
Co-crystal E-58425 (Tramadol/Celecoxib): Two immediate release oral over-encapsulated tablets of 100 mg, every 12 hours for 48 hours.
Tramadol (Ultram®)
Tramadol: One immediate release oral over-encapsulated tablet of 50 mg, every 6 hours for 48 hours.
Celecoxib (Celebrex®)
Celecoxib: One immediate release oral over-encapsulated capsule of 100 mg, every 12 hours for 48 hours.
Placebo
Placebo 100 mg or 200 mg oral over-encapsulated tablets every 6 hours for 48 hours.
Chesapeake Research Group, LLC, Pasadena
Optimal Research, LLC, Austin
Jean Brown Research, Salt Lake City
Arizona Research Center, Phoenix
Anaheim Clinical Trials, LLC, Anaheim
Collaborators (1)
Premier Research Group plc
UNKNOWN
Laboratorios del Dr. Esteve, S.A.
INDUSTRY